Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABT compared with ABBV: revenue, margins and what each company keeps, and the suppliers and customers both name
ABT
Abbott Laboratories
Change
Mkt cap
Revenue
Revenue
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABT
Abbott Laboratories
vs
ABBV
AbbVie Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
ABT
Abbott Laboratories
Change
109.10
▼
−0.97%
Mkt cap
$190.6B
Revenue
$12.6B
Q2 FY26
Revenue
$44.3B
FY25
ABBV
AbbVie Inc.
Change
285.95
▼
−1.00%
Regular session
Nov 3 '26
Mkt cap
$510.4B
Revenue
$17.4B
Q3 FY26
Revenue
$61.2B
FY25
vs
Compare
Regular session
Nov 3 '26
ABT
Abbott Laboratories
vs
ABBV
AbbVie Inc.
109.10
▼
−0.97%
Price
285.95
▼
−1.00%
$190.6B
Mkt cap
$510.4B
Q2 FY26
$12.6B
Revenue
$17.4B
Q3 FY26
FY25
$44.3B
Revenue
$61.2B
FY25
Change
Change
ABT
109.10
▼
−0.97%
vs
ABBV
285.95
▼
−1.00%
Regular session
Nov 3 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ABT
7
PODD
Insulet
supplier
ITGR
Integer
supplier
GPK
Graphic Packaging
supplier
TNDM
Tandem Diabetes Care
customer
3 more · ABT chain
›
Shared
0
No shared counterparties.
Only ABBV
19
MCK
McKesson
customer
CAH
Cardinal Health
customer
NBIX
Neurocrine Biosciences
customer
IMNM
Immunome
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
15 more · ABBV chain
›